Background: Reverse total shoulder arthroplasty (RTSA) procedures have significantly increased in the last decade as an alternative to the current treatments for cuff-tear arthropathy. Since Grammont's theory in 1987, few data about the in vivo kinetics of the shouldergirdle musculature in patients with RTSA have been available. The goals of this study are to (1) describe the contribution of principal muscles around the shoulder by electromyography and (2) access the range of motion of 5 movements of patients with RTSA compared with normal shoulders. Methods: This is an observational prospective cohort study of 21 patients divided into 11 patients with RTSA and 10 controls. The muscular activity was recorded with bipolar cutaneous electrodes, whereas the range of motion was synchronized and recorded by 8 motion cameras. Five movements (flexion, abduction, neutral external rotation, external rotation in 90 of abduction, and internal rotation in 90 of abduction) were studied. Results: The upper trapezius is the main activator in all directions with early and constant activity (P < .01). The latissimus dorsi demonstrates increased muscular activity in internal rotation (P < .01) as well as the posterior deltoid in external rotation in the RTSA group compared with control (P < .01). Conclusion: RTSA shoulder muscle activation is significantly different than in normal shoulders. The significant contribution of the trapezius in all directions, latissimus dorsi in internal rotation, and posterior deltoid in external rotation has never been described within the same study until today. New rehabilitation protocols targeting those muscles could demonstrate better and more homogeneous results and increase patient satisfaction.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.